Form 4: KORU Medical Systems COO Christopher Pazdan Reports Stock and Option Awards

Chief Operating Officer Christopher Pazdan reports the acquisition of restricted stock units and options in KORU Medical Systems, Inc.

Summary

• Christopher Pazdan, the Chief Operating Officer of KORU Medical Systems, Inc., filed a Form 4.
• The filing reports the acquisition of 20,255 restricted stock units that vest over time and upon a change in control.
• An additional 20,255 restricted stock units were acquired that vest based on performance conditions as of December 31, 2026, with potential payout ranging from 0% to 150% depending on performance.
• Pazdan also acquired options to buy 44,721 shares of common stock, vesting over four years.
• All transactions occurred on August 15, 2024.
• Following the reported transactions, Pazdan directly owns 20,255 restricted stock units, 20,255 restricted stock units based on performance, and options to buy 44,721 shares of common stock.

Sentiment

Score: 6

Explanation: The document is a standard SEC filing detailing stock and option awards to a company executive. It doesn't inherently convey positive or negative sentiment, but rather provides factual information about insider transactions.

Positives

• The grant of restricted stock units and options to the COO aligns his interests with those of the shareholders.
• The performance-based vesting of some restricted stock units incentivizes the COO to achieve company performance goals.

Future Outlook

The restricted stock units vest over time and based on performance, indicating a long-term incentive plan for the COO.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders.

Stakeholder Impact

• The stock and option awards align the COO's interests with those of shareholders, potentially driving long-term value creation.

Key Dates